
One Equity Partners ("OEP") makes private equity investments behind compelling business ideas and strong management teams. Established in 2001, OEP manages $8 billion of investments and commitments for JPMorgan Chase & Co. in direct private equity transactions. Partnering with management, OEP invests in transactions that initiate strategic and operational changes in businesses to create long-term value. OEP's investment professionals are located across North America, Europe and Asia, with offices in New York, Chicago, Menlo Park, Frankfurt and Hong Kong.One Equity Partners acts as a lead equity investor in management-led buyouts, and growth capital financing with a particular emphasis on corporate partnerships and divestitures. OEP typically invests $50 million to $200 million per transaction but historical investments have ranged from $3 million to over $500 million.We are constantly looking for companies in growing or changing industries and management teams who share our creative approach to commerce. We believe that our capital is best used to help these managers change their businesses and achieve their goals. Our sole funding relationship with JP Morgan Chase & Co. enables us to be as patient as needed to achieve success. Over recent years, OEP has invested approximately $5 billion to acquire over forty companies in a variety of industries including defense, chemicals, healthcare, technology, travel and manufacturing. Representative current companies include Carlson Wagonlit Travel, GlobalPack, NCO Group, Prodigy Health Group, and Sud Chemie. To date, OEP has led all of these transactions. |
![]() ![]() February 24, 2010
GENBAND Selected to Acquire Nortel’s CVAS Assets February 8, 2010
Faurecia Combined Shareholders' Meeting: Contribution of Emcon Technologies and new governance January 7, 2010
Read More News
China Medicine Corporation Enters Into a $69.6 Million Financing Agreement with One Equity Partners |




Quintiles Transnational Corp. (“Quintiles”), is the global market leader in outsourced product development and commercialization services to pharmaceutical and biotech companies.
OEP believes the Company will benefit from the trends affecting the pharmaceutical industry.
OEP purchased Quintiles in September 2003, and sold it in January 2008, for a gross IRR of 75%.



![]() |
|
![]() |
|

| New York One Equity Partners LLC 320 Park Ave, 18th Floor Between 50th and 51st New York, NY 10022 Tel: (212) 277-1500 Fax: (212) 277-1533 | Chicago One Equity Partners LLC 10 South Dearborn,14th Floor Chicago, IL 60603-2003 Tel: (312) 732-6281 Fax: (312) 732-7495 | Menlo Park One Equity Partners LLC 2420 Sand Hill Road Suite 203, 1st Floor Menlo Park, CA 94025-6943 Tel: (650)233-0411 Fax: (650)233-0811 | ||
| Frankfurt, Germany One Equity Partners Europe Taunusanlage 21 60325 Frankfurt am Main Germany Tel: (49) 69 5060-747-0 Fax: (49) 69 5060 747-40 | Hong Kong 19/F Two Exchange Square 8 Connaught Place Central Hong Kong Telephone: (852) 2800 0182 | |||